Ardelyx
ARDX
$6.54
Share price
2.11%
Change (1 day)
40.54%
Change (1 year)
Categories
Ardelyx (ARDX) - Net assets
Net assets on the balance sheet as of December 2023 : $0.16 B
According to Ardelyx's latest financial reports the company has $0.16 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Ardelyx - Net assets on balance sheet (from 2013 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.16 B | 69.65% |
| 2022-12-31 | $98.32 M | 19.02% |
| 2021-12-31 | $82.61 M | -34.49% |
| 2020-12-31 | $0.12 B | -32.44% |
| 2019-12-31 | $0.18 B | 61.17% |
| 2018-12-31 | $0.11 B | -16.87% |
| 2017-12-31 | $0.13 B | -27.87% |
| 2016-12-31 | $0.19 B | 77.36% |
| 2015-12-31 | $0.10 B | 79.46% |
| 2014-12-31 | $60.68 M | -928.54% |
| 2013-12-31 | $-7.33 M | 492.08% |
| 2012-12-31 | $-1.24 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | $38.82 B | 23,175.35% | 🇺🇸 USA |
 Amgen AMGN | $6.23 B | 3,635.85% | 🇺🇸 USA |
 Sanofi SNY | $82.20 B | 49,177.89% | 🇫🇷 France |
 AstraZeneca AZN | $37.50 B | 22,380.46% | 🇬🇧 UK |
 OPKO Health
OPK | $1.38 B | 732.79% | 🇺🇸 USA |